[Modern trends in therapy of chronic pulmonary hypertensive cardiopathy].
D000111:Acetylcysteine / Q000627:therapeutic use; D000142:Acidosis, Respiratory / Q000628:therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D001815:Bloodletting; D001993:Bronchodilator Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy*; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011175:Positive-Pressure Respiration; D011189:Potassium Chloride / Q000627:therapeutic use; D011660:Pulmonary Heart Disease / Q000628:therapy*; D013565:Sympatholytics / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D001993:Bronchodilator Agents; D000697:Central Nervous System Stimulants; D004232:Diuretics; D006993:Hypnotics and Sedatives; D013565:Sympatholytics; D011189:Potassium Chloride; D000324:Adrenocorticotropic Hormone; D000111:Acetylcysteine
Moderni orientamenti nella terapia della cardiopatia ipertensiva polmonare cronica.